News Archive - 2010

News Archive - 2010

Chronic Fatigue Syndrome is not caused by XMRV

Chronic Fatigue Syndrome is not caused by XMRV

New research shows XMRV virus is a laboratory contaminant

A virus previously thought to be associated with chronic fatigue syndrome is not the cause of the disease, a detailed study has shown. The research shows that cell samples used in previous research were contaminated with the virus identified as XMRV and that XMRV is present in the mouse genome.

The genetic basis of brain diseases

The genetic basis of brain diseases

A set of brain proteins is found to play a role in over 100 brain diseases and provides a new insight into evolution of behaviour

In research published today, scientists have studied human brain samples to isolate a set of proteins that accounts for over 130 brain diseases. The paper also shows an intriguing link between diseases and the evolution of the human brain.

Genetic markers for blood clot found

Genetic markers for blood clot found

Study provides new avenues to understanding biology of heart disease

The study, published this week in the leading haematology journal Blood, could inform ways of detecting and treating coronary heart disease - the most common form of disease to affect the heart and an important cause of premature death.

39 new genetic associations with Crohn's disease

39 new genetic associations with Crohn's disease

UK-led research links more genes to Crohn's disease than any other condition

New research has more than doubled the number of genes known to be linked to Crohn's disease, bringing the total to 71. The results - published in the journal Nature Genetics - mean that more genes are now associated with Crohn's than with any other disease.

Sanger Institute researcher among first to receive Rutherford Discovery Fellowship

Sanger Institute researcher among first to receive Rutherford Discovery Fellowship

Paul Gardner receives Royal Society of New Zealand award

Sanger Institute Researcher Dr Paul Gardner is one of the first researchers to receive the inaugural Rutherford Discovery Fellowship. The award will support Paul as he embarks on new computational research to understand how RNAs - a group of molecules found in all forms of life - contribute to the chemical processes underlying biology.

Sanger researcher awarded Cancer Research UK prize

Sanger researcher awarded Cancer Research UK prize

Dr Peter Campbell is future leader in his field

Dr Peter Campbell, group leader in the Wellcome Trust Sanger Institute's Cancer Genome Project, has been awarded the first-ever Cancer Research UK Future Leaders Prize. The accolade recognises scientists who show the potential to be world-class researchers in their field.

1000 Genomes Project publishes analysis of completed pilot phase

1000 Genomes Project publishes analysis of completed pilot phase

Produces tool for research into genetic contributors to human disease

Today in the journal Nature, the 1000 Genomes Project, an international public-private consortium, published the most comprehensive map of these genetic differences, called variations, estimated to contain approximately 95 per cent of the genetic variation of any person on Earth.

Forces for cancer spread: genomic instability and evolutionary selection

Forces for cancer spread: genomic instability and evolutionary selection

Pancreatic cancer genomes show remarkable mutation effects

In new research published today, researchers uncover evolution in action in cancer cells. They show the forces of evolution in pancreatic tumours mean that not only is cancer genetically different between different patients, but each new focus of cancer spread within a patient has acquired distinct mutations.

When one is not enough: finding hyper-sensitive genes

When one is not enough: finding hyper-sensitive genes

Study reveals genetic signatures for childhood developmental disorders caused by the loss of one of the two copies of a gene

n this study, scientists compared these sensitive genes with more than 1000 non-sensitive genes to find common genetic 'signposts' that could then be used to predict whether a gene is likely to be sensitive or not.

PiggyBac joins armoury in fight against cancer

PiggyBac joins armoury in fight against cancer

Powerful mutation tool identifies new cancer genes

Researchers have developed a genetic tool in mice to speed the discovery of novel genes involved in cancer. The system - called PiggyBac - has already been used by the team to identify novel candidate cancer-causing genes.

Pages